The Influence of Internal and External Support on Innovation Ability of Medical Device Enterprises: Based on a Study of Listed Medical Device Companies_Vol. 1 No. 3 (JMSD 2024)_Journal of Management and Social Development (ISSN: 3005-5741)

Home > Journal of Management and Social Development (ISSN: 3005-5741) > Vol. 1 No. 3 (JMSD 2024) >

The Influence of Internal and External Support on Innovation Ability of Medical Device Enterprises: Based on a Study of Listed Medical Device Companies

Download PDF

DOI: https://doi.org/10.62517/jmsd.202412310

Author(s)

Chuting He1, Bu Shuyi2, Deng Jiayao1, Peng Chenghua3, Zeng Yaqi1, Xin Meiqian1, Liang Ting1, Liu Yutong1, Ma LuBu1, Qingfeng 1,*

Affiliation(s)

1School of Medical Instruments, Shanghai University of Medicine and Health, Shanghai, China 2Yangpu Senior High School, Shanghai, China 3Jining Technical College, Jining, China *Corresponding Author

Abstract

As a high-tech industry, improving innovation capabilities in the medical device industry is an important manifestation of responding to the call of the country to build a world science and technology powerhouse. This study takes 43 listed medical device enterprises in China from 2018 to 2022 as samples to explore the impact of internal human, material and financial resources as well as external government R&D funding support on innovation ability. After reviewing the literature and considering the availability of data, the index system was established and the empirical research was carried out by stepwise regression. The results showed that the internal input of human resources and capital of medical device enterprises had a positive promoting effect on the innovation ability of enterprises. The equipment invested in R&D has a significant negative impact on the innovation ability of enterprises. The government investment outside the medical device enterprise has a negative impact on the innovation ability of the enterprise, but it is not obvious. After regression analysis, multicollinearity test was carried out to verify the reliability of the regression results again. Therefore, the internal research and development investment of medical device enterprises should pursue the balance between marginal income and marginal cost, and the government should pay attention to the rationality and efficiency of providing research and development funding support.

Keywords

Medical Device Enterprise; Enterprise Innovation Input; Innovation Ability

References

[1] J. Schumpeter. Economic Development theory [M]. Beijing: The Commercial Press, 2000 [2] He Yujing, CAI Danyang. Analysis on green technology innovation efficiency and its influencing factors of industrial enterprises in Yangtze River Delta [J]. Chongqing Social Sciences, 2021(01): 49-63. [3] Fang Wei, Zheng Liming. Research on regional differences and influencing factors of technology transfer efficiency in civil-military integration enterprises [J]. Operations Research and Management, 2020, 29(08): 1-11. [4] Zhang Tian, Yu Boyang. Research on Efficiency evaluation of innovation system in strategic emerging industries in China: A case study of medical device industry [J]. Jiangsu Social Sciences,2019,(03):76-85. [5] Marc Lankhorst. How Enterprise Architects Can Contribute to Innovation [EB/OL].(2019-2-20)[2024-3-11].https://bizzdesign.com/blog/how-enterprise-architects-can-contribute-to-innovation/#:~:text=How%20Enterprise%20Architects%20Can%20Contribute%20to%20Innovation%201,Processes%20and%20Results%20...%205%20Involving%20Everyone%20 [6] CHENG Yu, Li Li, WANG Xiangqian et al. Situational difference, performance-based equity incentive and Enterprise innovation: A study of listed companies in medical device industry [J]. Journal of Central University of Finance and Economics,2023,(09):72-82. [7] Jiang Zhaojun, Wu Zhibin. The influence of knowledge spillover from cultural industry clusters on enterprise innovation ability: A case study of national advertising industrial Parks [J]. Jianghuai Forum,2020(06) [8] Jiang L. Study on the influence of pharmaceutical manufacturing industry agglomeration on regional innovation ability and green development [D]. Hebei University of Economics and Business,2018. [9]Ashraf R, Ray R.Human Capital, Skilled Immigrants, and Innovation[J].SSRN Electronic Journal, 2016. [10] Liu Xin, Dong Jiwei, Luo Xiqing et al. Research on China's medical device industry policy text from the dual perspective of policy tools and innovation value chain [J]. Chinese Journal of Medical Administration, 2019,13(05):22-28. [11] Wu Ying, Zhang Yi. Digital economy and regional innovation: from the perspective of financing and intellectual property protection [J]. Southern Economy, 2021(9):16. [12] Wang Na. Research on incentive effect of tax incentives on technological innovation of medical device enterprises [D]. Liaoning University,2023. [13]Lin C H , Jang S L .The impact of M&As on company innovation: evidence from the US medical device industry[J].Scientometrics,2010, 84(1):119-131. [14]Svistounov A , Kestell C , Adams K ,et al.Effects of medical device legislation on innovation within Australian manufacturing companies[J].Innovation, 2014. [15] Zhao Yanyun, Liu Siming. An empirical study on the impact of patents on economic growth patterns in China: 1988-2008 [J]. Journal of Quantitative and Technical Economics, 2011(4): 34-48, 81. [16] Jie Zhang, Debu Gao, Yinlei Xia. Whether patents can promote China's economic growth: An explanation from the perspective of China's patent funding policy. China Industrial Economics,2016(1) :83-98 [17] Life cycle, fiscal policy and innovation capability: Empirical evidence from technology-based smes [J]. Contemporary Finance and Economics,2018(03):23-34. [18] Yang Zhiqing, Zhang Fan, Zhang Youdou. How government subsidies affect enterprise innovation in competitive fields [J]. Finance and Trade Economics,2019,40(09):132-145. [19] Lach S .Do R&D Subsidies Stimulate or Displace Private R&D? Evidence from Israel[J].Journal of Industrial Economics, 2002, 50(4):págs.369-390. [20] Yin Shuying, Chen Litai. Research on technological innovation efficiency of Chinese pharmaceutical enterprises based on two-stage SFA model [J]. Soft Science,2016,30(05):54-58. [21] Zhang Chun, Fang Ping. On Ownership structure and Performance of Private Listed Companies in China [J]. Journal of Shanghai University (Social Sciences),2009,16(02):90-105. (in Chinese) [22] Zhan Yubo, Sun Xin, Zeng Junhui. Credit constraints, profitability and innovation decision-making: Panel evidence from Chinese high-tech firms [J]. Shanghai Economic Research,2018(11):90-100. [23] Yang Yang.Research on the impact of government subsidies on innovation performance of listed companies in medical device industry [J]. Certified Public Accountants,2023(03):18-21. [24] Gao Lingyan. Analysis of enterprise growth ability -- Based on the comparative analysis of Yili Group and Mengniu Group [J]. China Commerce and Trade,2014(06):6-8. [25] Sun Fenge, Tian Zhiwei. The way to improve regional innovation efficiency: selective protection or comprehensive opening [J]. Science and Technology Progress and Countermeasures,2019,36(08):35-43. (in Chinese) [26] Qi Xiaoqing. Analysis of fixed asset investment benefit and its delayed benefit [J]. Modern Economic Information, 2019(07):294.